Proline <i>cis</i>/<i>trans</i> Conformational Selection Controls 14–3–3 Binding
Intrinsically disordered protein regions (IDRs) are structurally dynamic yet functional, often interacting with other proteins through short linear motifs (SLiMs). Proline residues in IDRs introduce conformational heterogeneity on a uniquely slow time scale arising from <i>cis</i>/<i>trans</i> isomerization of the Xaa-Pro peptide bond. Here, we explore the role of proline isomerization in the interaction between the prolactin receptor (PRLR) and 14-3-3. Using NMR spectroscopy, thermodynamic profiling, and molecular dynamics (MD) simulations, we uncover a unique proline isomer-dependent binding, with a <i>cis</i> conformation affinity 3 orders of magnitude higher than the <i>trans</i>. MD simulations identify structural constraints in the narrow 14-3-3 binding groove that provide an explanation for the observed isomer selectivity. The <i>cis</i> preference of WT PRLR introduces a slow kinetic component relevant to signal propagation and a steric component that impacts chain direction. Proline isomerization constitutes a previously unrecognized selective component relevant to the ubiquitous 14-3-3 interactome. Given the prevalence of prolines in IDRs and SLiMs, our study highlights the importance of considering the distinct properties of proline isomers in experimental design and data interpretation to fully comprehend IDR functionality.
Authors
- Birthe B. Kragelund (ORCID: https://orcid.org/0000-0002-7454-1761)
- Nina L. Jacobsen (ORCID: https://orcid.org/0000-0002-8264-0057)
- Andreas Prestel (ORCID: https://orcid.org/0000-0002-5459-9608)
- Johan G. Olsen (ORCID: https://orcid.org/0000-0001-8805-6372)
- Frederik Friis Theisen (ORCID: https://orcid.org/0000-0002-3412-4242)
- Oline K. Nyhegn-Eriksen
Institutions
- University of Copenhagen (DK)
- Institut de Biologie Structurale (FR)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1021/jacs.4c13462
- Citations
- 8
- Primary Topic
- 14-3-3 protein interactions
- Type
- article
- Field-Weighted Citation Impact
- 6.45
Funders
- Novo Nordisk
- Novo Nordisk Fonden